Repression of vascular endothelial growth factor expression by the zinc finger transcription factor ZNF24

被引:46
作者
Harper, Jav
Yan, Li
Loureiro, Robyn M.
Wu, Iinmin
Fang, Jianmin
D'Amore, Patricia A.
Moses, Marsha A.
机构
[1] Childrens Hosp, Vasc Biol Progam, Boston, MA 02115 USA
[2] Harvard Med Sch, Dept Surg, Boston, MA USA
[3] Harvard Med Sch, Schepens Eye Res Inst, Boston, MA USA
[4] Centocor R&D Inc, Malvern, PA USA
[5] Cell Genesys Inc, Dept Preclin Oncol & Immunol, San Francisco, CA USA
关键词
D O I
10.1158/0008-5472.CAN-07-1617
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Vascular endothelial growth factor (VEGF) is a potent stimulator of angiogenesis. Although many positive regulators of VEGF have been identified, relatively little is known regarding the negative regulation of VEGF expression. We identified a zinc finger transcription factor, ZNF24, that may repress VEGF transcription. An inverse correlation between expression of VEGF and ZNF24 was observed in a series of independent studies. ZNF24 was up-regulated in angiogenic tumor nodules where VEGF expression is significantly decreased compared with preangiogenic nodules. In human breast carcinoma cells cultured under normoxic conditions, ZNF24 levels were significantly up-regulated whereas VEGF levels were low. In contrast, VEGF was significantly increased in hypoxic cells whereas ZNF24 was down-regulated. The same inverse correlation between ZNF24 and VEGF was also observed in 70% of matched cDNA pairs of normal and malignant tissues from human colon and breast biopsies. Overexpression of ZNF24 resulted in a significant down-regulation of VEGF, whereas silencing of ZNF24 with small interfering RNA led to increased VEGF expression. Cotransfection of ZNF24 and a VEGF promoter luciferase reporter construct in MDA-MB-231 cells resulted in a significant decrease in VEGF promoter activity. Taken together, these data suggest that ZNF24 is involved in negative regulation of VEGF and may represent a novel repressor of VEGF transcription.
引用
收藏
页码:8736 / 8741
页数:6
相关论文
共 32 条
[1]   SUPPRESSION OF RETINAL NEOVASCULARIZATION IN-VIVO BY INHIBITION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) USING SOLUBLE VEGF-RECEPTOR CHIMERIC PROTEINS [J].
AIELLO, LP ;
PIERCE, EA ;
FOLEY, ED ;
TAKAGI, H ;
CHEN, H ;
RIDDLE, L ;
FERRARA, N ;
KING, GL ;
SMITH, LEH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (23) :10457-10461
[2]   Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele [J].
Carmeliet, P ;
Ferreira, V ;
Breier, G ;
Pollefeyt, S ;
Kieckens, L ;
Gertsenstein, M ;
Fahrig, M ;
Vandenhoeck, A ;
Harpal, K ;
Eberhardt, C ;
Declercq, C ;
Pawling, J ;
Moons, L ;
Collen, D ;
Risau, W ;
Nagy, A .
NATURE, 1996, 380 (6573) :435-439
[3]   Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein [J].
Cockman, ME ;
Masson, N ;
Mole, DR ;
Jaakkola, P ;
Chang, GW ;
Clifford, SC ;
Maher, ER ;
Pugh, CW ;
Ratcliffe, PJ ;
Maxwell, PH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (33) :25733-25741
[4]   Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model [J].
Fang, JM ;
Shing, Y ;
Wiederschain, D ;
Yan, L ;
Butterfield, C ;
Jackson, G ;
Harper, J ;
Tamvakopoulos, G ;
Moses, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (08) :3884-3889
[5]  
Fang JM, 2001, CANCER RES, V61, P5731
[6]   Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene [J].
Ferrara, N ;
CarverMoore, K ;
Chen, H ;
Dowd, M ;
Lu, L ;
OShea, KS ;
PowellBraxton, L ;
Hillan, KJ ;
Moore, MW .
NATURE, 1996, 380 (6573) :439-442
[7]   Molecular cloning of six novel Kruppel-like zinc finger genes from hematopoietic cells and identification of a novel transregulatory domain KRNB [J].
Han, ZG ;
Zhang, QH ;
Ye, M ;
Kan, LX ;
Gu, BW ;
He, KL ;
Shi, SL ;
Zhou, J ;
Fu, G ;
Mao, M ;
Chen, SJ ;
Yu, L ;
Chen, Z .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (50) :35741-35748
[8]   ALLELIC LOSS IN COLORECTAL-CARCINOMA [J].
KERN, SE ;
FEARON, ER ;
TERSMETTE, KWF ;
ENTERLINE, JP ;
LEPPERT, M ;
NAKAMURA, Y ;
WHITE, R ;
VOGELSTEIN, B ;
HAMILTON, SR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (21) :3099-3103
[9]  
Klagsbrun Michael, 1996, Cytokine and Growth Factor Reviews, V7, P259, DOI 10.1016/S1359-6101(96)00027-5
[10]   Regulation of an endogenous locus using a panel of designed zinc finger proteins targeted to accessible chromatin regions - Activation of vascular endothelial growth factor A [J].
Liu, PQ ;
Rebar, EJ ;
Zhang, L ;
Liu, Q ;
Jamieson, AC ;
Liang, YX ;
Qi, H ;
Li, PX ;
Chen, BL ;
Mendel, MC ;
Zhong, XH ;
Lee, YL ;
Eisenberg, SP ;
Spratt, SK ;
Case, CC ;
Wolffe, AP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (14) :11323-11334